Jump to content

MBL deficiency

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Akrasia25 (talk | contribs) at 00:24, 4 February 2020 (Importing Wikidata short description: "Human disease" (Shortdesc helper)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

MBL deficiency
SpecialtyImmunology

MBL deficiency is a pathology of the innate immune system involving Mannan-binding lectin pathway components such as MBL2.

It is thought that 5–10% of the population have an MBL deficiency of some degree.[1] There are varying degrees of MBL deficiency; some people will not even know they have the deficiency, while others may have such low levels that they experience infections with great frequency. Babies and young children are most at risk.

References

  1. ^ "Mannose-binding lectin deficiency". Genetics Home Reference. U.S. National Library of Medicine.


This article about a medical condition affecting the circulatory system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=MBL_deficiency&oldid=939043028"